Evaluating thrombosis risks related to vascular catheters after major surgery
Comparison of Vascular Catheter-Related Thrombosis and Risk Factors Using Daily Bedside Ultrasonography After Oncologic and Non-Oncologic Major Surgery
This study is testing how often blood clots happen in patients with vascular catheters after major surgery to help improve safety and treatment options.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Mersin University Academic / other |
| Locations | 1 site (Mersin, Yenişehir) |
| Trial ID | NCT06635551 on ClinicalTrials.gov |
What this trial studies
This study aims to prospectively assess the incidence of vascular catheter-related thrombosis (VCRT) and its associated risk factors in adult patients undergoing major oncologic and non-oncologic surgeries. Utilizing daily bedside ultrasonography, the study will monitor patients for signs of VCRT from the day of catheter placement until removal. The research seeks to clarify the timeline and evolution of VCRT, which can lead to serious complications like pulmonary embolism. By identifying risk factors and monitoring thrombosis development, the study hopes to improve patient outcomes and intervention strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients aged 18-80 undergoing major surgery who do not have conditions that predispose them to hypercoagulability.
Not a fit: Patients with renal failure, hematological malignancies, or those who are pediatric may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better prevention and management of vascular catheter-related thrombosis, reducing complications for surgical patients.
How similar studies have performed: While there have been studies on VCRT in intensive care settings, this specific focus on major surgery patients is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient (18-80 years old) * No hematological disease causing hypercoagulability * Not receiving anticoagulant/antifibrinolytic medications at the therapy dose * The vascular structure can be visualized with US * No thrombosis in the US control before catheter placement * The catheter is not inserted for renal replacement therapy Exclusion Criteria: * Presence of renal failure * Pediatric patients * Presence of hematological malignancy * Inadequate US imaging
Where this trial is running
Mersin, Yenişehir
- Mersin University — Mersin, Yenişehir, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Levent Özdemir — Mersin University, Faculty of Medicine, Mersin, Turkiye
- Study coordinator: Levent Özdemir
- Email: leventozdemirmd@gmail.com
- Phone: +905324867051
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.